Provided is a use of anagrelide in the preparation of a pharmaceutical composition treating cancer, the cancer comprising lung cancer, bladder cancer, kidney cancer, cervical cancer, prostate cancer, breast cancer, ovarian cancer, gastric cancer, liver cancer, colorectal cancer, pancreatic cancer, tongue cancer etc.Linvention concerne une utilisation de lanagrélide dans la préparation dune composition pharmaceutique de traitement du cancer, le cancer comprenant le cancer du poumon, le cancer de la vessie, le cancer du rein, le cancer du col de lutérus, le cancer de la prostate, le cancer du sein, le cancer de lovaire, le cancer gastrique, le cancer du foie, le cancer colorectal, le cancer du pancréas, le cancer de la langue, etc.
